BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 21, 2017
View Archived Issues
First-described mouse model for moyamoya disease
Read More
Atossa Genetics receives positive interim review of phase I endoxifen trial
Read More
uniQure decides not to seek marketing authorization renewal for Glybera in Europe
Read More
A novel live-attenuated Zika virus vaccine demonstrates promising safety and efficacy in mice
Read More
First patient treated in phase II trial of OXS-1550
Read More
Novel SERD G1T48 shows preclinical efficacy for breast cancer
Read More
PTC Therapeutics completes acquisition of U.S. rights to Emflaza for Duchenne muscular dystrophy
Read More
FDA issues complete response letter for CCP-07
Read More
Cyclophilin inhibitor NV-556 shows preclinical promise for liver fibrosis in NASH
Read More
New ER stress inhibitors as probe compounds to investigate treatments for neurodegenerative diseases
Read More
Jounce begins phase II portion of ICONIC trial of JTX-2011
Read More
Phase III GLOBE study of VB-111 in recurrent GBM recommended to continue
Read More
FDA grants orphan drug designation to Efranat's EF-022
Read More
EMA renders negative trend vote on XBiotech's MAA for colorectal cancer candidate antibody
Read More
ReNeuron updates progress of stroke disability and retinal disease programs
Read More
BMS-986158 shows promise for cancer treatment
Read More
Galileo Research's non-restricted T-cell line receives orphan drug designation
Read More
Saniona achieves second Parkinson's milestone under Michael J. Fox Foundation grant
Read More
Nissan Chemical and Shionogi form analgesic research collaboration
Read More
Pierre Fabre Medicament and CNRS present DNMT1 and DNMT3 inhibitors
Read More
Grail initiates STRIVE study to validate blood test to detect breast cancer
Read More
FDA grants orphan drug status to Lonsurf for the treatment of gastric cancer
Read More
Quartet Medicine and EPFL patent SPR inhibitors
Read More
Selvita SA divulges LDHA and LDHB inhibitors
Read More
Japanese approval sought for guselkumab
Read More
Basilea reaches SPA agreement with FDA on phase III studies of ceftobiprole
Read More